^
    Back
    Association details:
    Biomarker:No biomarker
    Cancer:Non-Hodgkin’s Lymphoma
    Regimen:DDGP
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: A2 - Guideline
    Source:
    NCCN
    Published date:
    01/05/2023
    Excerpt:
    Extranodal NK/T-Cell Lymphomas...INDUCTION THERAPY….Preferred regimens...DDGP (dexamethasone, cisplatin, gemcitabine, and pegaspargase) x 3–6 cycles.